Source: Annual Congress 2004 - Modern techniques bringing new insights into cystic fibrosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bucchioni, D. Costantini, F. Blasi, T. Cappelletti, A. Brivio, C. Colombo, L. Allegra (Milan, Italy). Correlation between decrease of leukotriene B-4 and reactive protein C in cystic fibrosis patients. Eur Respir J 2004; 24: Suppl. 48, 2388

Member's Comments

No comment yet.

Related content which might interest you: Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis Source: Eur Respir J 2014; 44: 394-404 Year: 2014 Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004 Correlation between inflammatory and oxidation markers in adults with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008 The expression of calgranulin B in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Airway bacterial colonization is associated with low vitamin D serum levels in children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Induced sputum glutathione levels are decreased in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation Source: Eur Respir J 2010; 35: 1264-1272 Year: 2010 Oxidation contributes to low glutathione in the airways of children with cystic fibrosis Source: Eur Respir J 2014; 44: 122-129 Year: 2014 Inflammation in cystic fibrosis patients: study of the eicosanoid pathway and severity correlations. Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway Source: Eur Respir J 2003; 21: 574-581 Year: 2003 High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005 Increased alveolar soluble annexin V promotes lung inflammation and fibrosis Source: Eur Respir J 2015; 46: 1417-1429 Year: 2015 Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients Source: Eur Respir J 2014; 44: 802-805 Year: 2014 Plasma level of total hydroperoxide (TH) as a marker of oxidative stress seems to be a useful index of disease severity in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Relationship between C reactive protein and gene and levels of alpha1-antitrypsin Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2009; 34: 1444-1451 Year: 2009 Targeting of cathepsin S reduces cystic fibrosis-like lung disease Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018 Year: 2019 Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with exacerbation rate and pulmonary function Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008